Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
Table 2
Patient characteristics at screening/baseline of month three of SWABIMS.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Patient characteristics at screening/baseline of month three of SWABIMS.